World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
33091
World Ranking
9684
National Ranking
4985

Rolf A. Brekken publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Rolf A. Brekken sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 437 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Rolf A. Brekken D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Rolf A. Brekken sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 96 D-Index — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Rolf A. Brekken is affiliated with The University of Texas Southwestern Medical Center in the United States. Their research spans multiple domains within biomedical sciences, with a particular emphasis on oncology, immunology, and molecular biology.

The main fields of study for their work include Medicine, Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology. Among the subfields, Oncology, Immunology, Molecular Biology, Cancer Research, and Cell Biology are prominent areas of contribution.

The scientist's research topics cover a range of critical issues in cancer biology and immune regulation. Notable areas of focus include:

  • Pancreatic and Hepatic Oncology Research
  • Phagocytosis and Immune Regulation
  • Immune cells in cancer
  • Cancer Immunotherapy and Biomarkers
  • Cancer Cells and Metastasis
  • Single-cell and spatial transcriptomics
  • Angiogenesis and VEGF in Cancer

Among recent publications, several highlight their involvement in advancing the understanding of tumor microenvironments and cancer-associated immune mechanisms. Some of the noted works are:

  • "Pancreatic cancer stroma: an update on therapeutic targeting strategies," 2020, Nature Reviews Gastroenterology & Hepatology
  • "Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer," 2022, Cancer Cell
  • "DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis," 2021, JCI Insight
  • "The Colorectal Cancer Tumor Microenvironment and Its Impact on Liver and Lung Metastasis," 2021, Cancers
  • "Cancer-Associated Fibroblasts: Versatile Players in the Tumor Microenvironment," 2020, Cancers

Frequent collaborators in their research include Huocong Huang, Jason E. Toombs, Debolina Ganguly, James B. Lorens, and John D. Minna, reflecting ongoing partnerships in advancing cancer research and immunology.

Their work has been published in key scientific venues that include:

  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancers
  • Journal of Clinical Oncology
  • JCI Insight

Best Publications

  • Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

    Gabriele Bergers;Rolf Brekken;Gerald McMahon;Thiennu H. Vu

  • Hypoxia-inducible factor 1α induces fibrosis and insulin resistance in white adipose tissue

    Nils Halberg;Tayeba Khan;Maria E. Trujillo;Maria E. Trujillo;Ingrid Wernstedt-Asterholm

  • SPARC, a matricellular protein: at the crossroads of cell-matrix.

    Rolf A. Brekken;E.Helene Sage

  • COMPOSITIONS AND METHODS FOR CANCER TREATMENT BY SELECTIVELY INHIBITING VEGF (VASCULAR ENDOTHELIAL GROWTH FACTOR)

    Thorpe Philip E;Brekken Rolf A

  • SPARC, a matricellular protein: at the crossroads of cell-matrix communication.

    Rolf A Brekken;E. H. Sage

  • Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer

    R. B. Birge;S. Boeltz;S. Kumar;J. Carlson

  • Pancreatic cancer stroma: an update on therapeutic targeting strategies.

    Abdel N. Hosein;Abdel N. Hosein;Rolf A. Brekken;Anirban Maitra

  • Role of VEGF-A in Vascularization of Pancreatic Islets

    Eckhard Lammert;Guqiang Gu;Margaret McLaughlin;Dennis Brown

  • Selective Inhibition of Vascular Endothelial Growth Factor (VEGF) Receptor 2 (KDR/Flk-1) Activity by a Monoclonal Anti-VEGF Antibody Blocks Tumor Growth in Mice

    Rolf A. Brekken;Jay P. Overholser;Victor A. Stastny;Johannes Waltenberger

  • Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth

    Romulo J C Albuquerque;Takahiko Hayashi;Won Gil Cho;Mark E Kleinman

  • Dichotomous effects of VEGF-A on adipose tissue dysfunction

    Kai Sun;Ingrid Wernstedt Asterholm;Christine M. Kusminski;Ana Carolina Bueno;Ana Carolina Bueno

  • Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo.

    Dana M Brantley;Nikki Cheng;Erin J Thompson;Qing Lin

  • 27-Hydroxycholesterol Promotes Cell-Autonomous, ER-Positive Breast Cancer Growth

    Qian Wu;Tomonori Ishikawa;Rosa Sirianni;Hao Tang

  • Angiogenic Role of LYVE-1-positive Macrophages in Adipose Tissue

    Chung Hyun Cho;Chung Hyun Cho;Young Jun Koh;Jinah Han;Hoon Ki Sung

  • Monitoring Response to Anticancer Therapy by Targeting Microbubbles to Tumor Vasculature

    Grzegorz Korpanty;Juliet G. Carbon;Paul A. Grayburn;Jason B. Fleming

  • A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth

    Lei Wang;Jianjun Chang;Diana Varghese;Michael T Dellinger

  • Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution.

    Abdel Nasser Hosein;Huocong Huang;Zhaoning Wang;Kamalpreet Parmar

  • A Peptoid "Antibody Surrogate" That Antagonizes VEGF Receptor 2 Activity

    D. Gomika Udugamasooriya;Sean P. Dineen;Rolf A. Brekken;Thomas Kodadek

  • Enhanced Expression of SPARC/Osteonectin in the Tumor-associated Stroma of Non-Small Cell Lung Cancer Is Correlated with Markers of Hypoxia/ Acidity and with Poor Prognosis of Patients

    Michael I. Koukourakis;Alexandra Giatromanolaki;Rolf A. Brekken;Efthimios Sivridis

  • Non-nuclear estrogen receptor α signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice

    Ken L. Chambliss;Qian Wu;Sarah Oltmann;Eddy S. Konaniah

Frequent Co-Authors

John D. Minna
John D. Minna The University of Texas Southwestern Medical Center
Jason B. Fleming
Jason B. Fleming The University of Texas MD Anderson Cancer Center
Philip E. Thorpe
Philip E. Thorpe The University of Texas Southwestern Medical Center
Luc Girard
Luc Girard The University of Texas Southwestern Medical Center
Adi F. Gazdar
Adi F. Gazdar The University of Texas Southwestern Medical Center
Michael A. White
Michael A. White Ideaya Biosciences (United States)
E. Helene Sage
E. Helene Sage Benaroya Research Institute
Ralph J. DeBerardinis
Ralph J. DeBerardinis The University of Texas Southwestern Medical Center
Pauli Puolakkainen
Pauli Puolakkainen University of Helsinki
Diego H. Castrillon
Diego H. Castrillon The University of Texas Southwestern Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative routes in the healthcare field can open up flexible and affordable career options. Many programs now offer fully online degrees and certificates, allowing students to balance work and study from anywhere in the world.

For registered nurses looking to advance, the cheapest bsn to dnp programs offer streamlined and budget-friendly paths to higher-level nursing roles. Similarly, those interested in pharmacy can consider pharm d online programs, which are designed for working professionals aiming to become licensed pharmacists.

Technology-savvy students might find opportunities in the digital management of health records. A health information technology online degree prepares graduates for in-demand roles managing patient data and health information systems.

Meanwhile, those seeking quick entry into the healthcare workforce may consider medical coding. If you’re wondering how much is medical billing and coding school, there are cost-effective online options to get certified and start working fast.

Best Scientists Citing Rolf A. Brekken

Trending Scientists